Loss of serglycin resulted in a lower number of angiogenic islets, an enhanced perfusion of the tumor vasculature and decreased levels of VEGF and HGF, suggesting that the presence of serglycin influences angiogenesis and vascular function. The gene discussed is SRGN; the disease is neoplasm.